HOME >> MEDICINE >> NEWS
Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers

Orqis Medical Corp. today announced that the U.S. Food and Drug Administration has approved an expansion of the Cancion CRSTM clinical trial from eight to 40 medical centers nationwide, accelerating the trial's recruitment and enrollment efforts.

The Cancion CRS therapy is a percutaneous cardiac recovery system being studied for its ability to create a "rest-to-recovery" environment for congestive heart failure (CHF) patients. Enrollment in the Multicenter trial of the Orqis Medical CRS for the ENhanced Treatment of CHF, Unresponsive to Medical Therapy (MOMENTUM) trial began in September of this year.

"We've worked with the FDA to develop an effective protocol for the MOMENTUM trial and are gratified that we can now ramp up to a full complement of sites," said Marvin A. Konstam, M.D., Medical Director of Orqis Medical and Chief of Cardiology at Tufts-New England Medical Center in Boston. "This puts us yet another step closer to our goal of documenting the value that the Cancion therapy can bring to patients with heart failure."

Heart failure is the deterioration of the heart's ability to pump blood throughout the body and adequately perfuse the major organs. According to the AHA, some five million Americans have heart failure and an additional 550,000 are diagnosed annually. The single most expensive diagnosis in the U.S. health care system, acutely decompensated heart failure, represents 1 million primary and 2.5 million secondary hospital admissions annually.

About The Cancion CRS Therapy
A breakthrough discovery in hemodynamics -- the simple supplementation of blood flow specifically in the descending aorta -- led to the development of the Cancion CRS therapy, which centers on the novel use of a blood pump and proprietary peripheral access to the circulatory system.

The Cancion CRS increases blood flow in the descending aorta without t
'"/>

Contact: Kimberly Goolsby
kimberly@goolsbygroup.com
949-464-0187
Goolsby Group
10-Jan-2005


Page: 1 2

Related medicine news :

1. New data on Orqis Medicals Cancion CRS to be reported at ACC
2. UIC professor receives international humanitarian award
3. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
4. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
5. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
6. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
7. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
8. American Academy of Neurology program receives Grassroots Award
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/15/2019)... ... October 15, 2019 , ... ... Most Recent IFU Guidance , **An FDAnews Webinar**, Tuesday, October 29, 2019, 1:30-3:00 ... Use (IFU) guidance have on new drug applications and biologics license applications? , ...
(Date:10/15/2019)... ... October 15, 2019 , ... Nashville Fertility Center (NFC) is proud to ... to join the practice. In addition to treating general infertility, Dr. Van Heertum offers ... at NFC looks forward to Dr. Van Heertum joining the practice and believes she ...
(Date:10/11/2019)... (PRWEB) , ... October 11, 2019 , ... A Topping ... (STA) new headquarters facility by general contractors Adolfson & Peterson Construction. The event celebrated ... 2020 at 8190 Midtown Road in Dallas. The first of its kind in Texas, ...
(Date:10/10/2019)... MATEO, Calif. (PRWEB) , ... October 10, 2019 , ... ... Senior Living Report on the Best and Worst Places for Seniors to Live. All ... options, community engagement, transportation, quality of life and workforce development. , According to ...
(Date:10/8/2019)... ... , ... What unique insights can three former Surgeons General of the United ... nation? That question will be answered at ICAA 2019: Shaping the Future of Wellness, ... will take place October 10-12, 2019, at the Gaylord Palms Resort and Convention Center ...
Breaking Medicine News(10 mins):
(Date:10/11/2019)... ... October 11, 2019 , ... On Sep. 8, 2019, General ... the grand opening for Long Island’s first-of-a-kind boutique CBD storefront. Located at 7A ... of CBD wellness products tailored to health-conscious consumers. , The retail shop is ...
(Date:10/10/2019)... ANGELES (PRWEB) , ... October 10, 2019 , ... ... a prolific producer of research in the field of reproductive medicine, with six ... the premier conference for reproductive experts, slated for October 12-16, 2019, in Philadelphia. ...
(Date:10/10/2019)... , ... October 10, 2019 , ... ... Gala Cocktail Reception on Thursday, September 26, at the Westchester Country Club in ... the unwavering support of the organization and its mission. , “In Celebration” featured ...
Breaking Medicine Technology:
Cached News: